Columbia Ventures Corporation

Name

Columbia Ventures Corporation

Legal name

Columbia Ventures Corporation

Website

https://colventures.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Private Equity Holding Company

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239), Other Financial Vehicles (52599)

akta.pro primary industry

Strategic / Balance-Sheet CVC (On-balance-sheet investing) (FSANAHAA)

Keywords

• Private equity holdings
• Diversified investment portfolio
• Venture capital investing
• Portfolio company management
• Multi-sector holding company

Headquarters

HQ city

Vancouver

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Investment Returns: As a private equity diversified holding company, CVC generates returns through equity appreciation, dividends, and exits from portfolio companies across biomedical, augmented reality, manufacturing, food, robotics, and telecommunications sectors.
2. Portfolio Company Equity: CVC holds equity positions in multiple portfolio companies including AbSci, Saladax Biomedical, RealWear, Matorka, Columbia Pulp, Willamette Falls Paper Company, Wilkinson Baking Company, and various telecommunications companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Columbia Ventures Corporation (CVC) is a private equity diversified holding company that acquires, develops, and manages portfolio investments across multiple sectors including augmented reality, biomedical, food, hospitality, manufacturing, real estate development, robotics, SaaS, and telecommunications. CVC identifies and invests in strategic, innovative, or contrarian opportunities, deriving returns through equity appreciation, dividends, and exits from its wholly-owned operating subsidiaries.

Product overview

Columbia Ventures Corporation (CVC) is a private equity diversified holding company that does not offer a single unified product but maintains a portfolio of independent portfolio companies across multiple sectors. The portfolio includes: RealWear (assisted reality AR headsets for frontline workers), AbSci (AI-powered synthetic biology platform for biologics drug discovery), Saladax Biomedical (MyCare point-of-care diagnostic tests), Matorka (aquaculture/fish farming), Columbia Pulp (wheat straw-based paper products), Willamette Falls Paper Company (coated freesheet paper), Wilkinson Baking Company (Breadbot robotic breadmaker), Lynk Global (satellite-to-phone connectivity), and Streem (mobile AR remote assistance).

Differentiator

Problem solved

Functional benefit

Products and services

• RealWear

Named customers12 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

13 partnerships are on record, tiered core and minor.

• CaltechcoreStrategic or Co-development Partner · 10 August 2023AbSci and Caltech collaboration to accelerate affordable HIV therapeutic vaccine development. Part of Bill Gates-funded research initiative targeting accessible HIV treatments.
• 2degreescoreGTM or Marketing Partner · 17 May 2023Lynk Global partnership with 2degrees to bring satellite-to-phone coverage to New Zealand.
• M2GENcoreStrategic or Co-development Partner · 5 April 2023AbSci partnership with M2GEN to expedite cancer drug development using AbSci's AI-powered synthetic biology platform.
• FLIR SystemscoreTechnology or Integration · 30 November 2022FLIR partnership with RealWear, a developer of AR wearables, integrating thermal imaging capabilities with assisted reality headsets.
• GMCO CorpminorStrategic or Co-development Partner · 10 January 2022Columbia Pulp new product launch in partnership with GMCO Corp of Colorado for eco-friendly fiber products.
• EQRxcoreStrategic or Co-development Partner · 6 October 2021AbSci and EQRx partnership to accelerate production of cheaper, protein-based therapeutics. Collaboration to discover and develop next-generation biologics.
• Ag Energy SolutionsminorStrategic or Co-development Partner · 23 September 2021Columbia Pulp partnership with Ag Energy Solutions for alternative products from residual wheat straw.
• Deutsche TelekomcoreGTM or Marketing Partner · 8 July 2020RealWear partnership with Deutsche Telekom to drive digital transformation for smart factories using AR technology.
• HLS TherapeuticscoreChannel Partner/ Reseller/ Distributor · 1 June 2020HLS Therapeutics became distributor of Saladax MyCare psychiatry line including the Insite point-of-care device and antipsychotic reagents.
• AVROBIOminorStrategic or Co-development Partner · 4 May 2020AVROBIO collaboration with Saladax Biomedical on new high-speed diagnostic assay development.
• SanoficoreStrategic or Co-development Partner · 9 January 2019AbSci collaboration with Sanofi using E. coli-based high titer expression platform for manufacturing protein therapeutics. Multiple announcements in January 2019 established the manufacturing partnership.
• Janssen (Johnson & Johnson)coreOEM/ Whitelabel/ Licensing Partner · 26 June 2018Saladax signed licensing agreement with Janssen for antipsychotic drug testing patents including clozapine monitoring tests.
• Siemens HealthineerscoreOEM/ Whitelabel/ Licensing Partner · 18 January 2017Saladax Biomedical licensed Alzheimer's diagnostic tests (amyloid beta 1-42 and tau biomarkers) to Siemens Healthineers for global commercialization.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Investment AB Kinnevik: Publicly listed Swedish investment holding company making long-term minority and majority investments across consumer internet, fintech, healthcare, and telecom. Most comparable to CVC in its diversified, owner-controlled, multi-sector holding structure with operating-company involvement.
• BDT & MSD Partners: Family-controlled merchant bank and investment firm backing owner-led and founder-led businesses across consumer, industrial, and tech. Comparable to CVC as a private, family-governed diversified investor with operational orientation and multi-decade holding periods.
• Jefferies Financial Group (Leucadia legacy): Diversified financial holding company historically operating like a permanent-capital vehicle with stakes across telecom, real estate, energy, and financial services. Comparable to CVC's diversified private-equity holding-company model and contrarian investment style.

Broad incumbents

• Temasek Holdings: State-owned Singapore investment company with long-term holdings across telecom, biotech, transport, and consumer. Comparable in scale and multi-sector, permanent-capital orientation, though larger and more institutionally governed than CVC.
• Berkshire Hathaway: The defining diversified holding company, with wholly-owned operating subsidiaries across insurance, industrials, energy, and consumer. Comparable to CVC in permanent-capital, owner-led, contrarian-capital allocation, though at vastly greater scale.
• 3i Group: Publicly listed private equity and venture investor with diversified European and global holdings across consumer, industrial, and technology. Comparable to CVC as a diversified, permanent-capital multi-sector investor, though more institutionally governed.
• Mubadala Investment Company: Abu Dhabi sovereign investor with diversified global holdings spanning biotech (e.g., Biogen stake), telecom, renewable energy, and advanced manufacturing. Comparable to CVC as a long-term, contrarian, multi-sector investor but at vastly larger scale.
• Prosus N.V. Listed global consumer internet and tech investor holding large stakes across food delivery, edtech, fintech, and classifieds. Comparable to CVC as a permanent-capital, multi-sector holding company with an operating-partner approach to portfolio companies.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/columbia-ventures-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Columbia Ventures Corporation